Intercept Pharmaceuticals, Inc. (ICPT) Quarterly Performance is -28.19%: Here is the Surprise Factor

Let’s start up with the current stock price of Intercept Pharmaceuticals, Inc. (ICPT), which is $46.70 to be very precise. The Stock rose vividly during the last session to $50 after opening rate of $47.25 while the lowest price it went was recorded $44.51 before closing at $77.49.

Intercept Pharmaceuticals, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $125.00 on 12/31/19, with the lowest value was $47.57 for the same time period, recorded on 06/29/20.

Intercept Pharmaceuticals, Inc. (ICPT) full year performance was -41.31%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Intercept Pharmaceuticals, Inc. shares are logging -62.64% during the 52-week period from high price, and -1.83% lower than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $47.57 and $125.00.

The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 10.26 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Intercept Pharmaceuticals, Inc. (ICPT) recorded performance in the market was -62.31%, having the revenues showcasing -28.19% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.58B, as it employees total of 583 workers.

Specialists analysis on Intercept Pharmaceuticals, Inc. (ICPT)

During the last month, 17 analysts gave the Intercept Pharmaceuticals, Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 78.76, with a change in the price was noted -51.18. In a similar fashion, Intercept Pharmaceuticals, Inc. posted a movement of -52.29% for the period of last 100 days, recording 728,537 in trading volumes.

Trends and Technical analysis: Intercept Pharmaceuticals, Inc. (ICPT)

Raw Stochastic average of Intercept Pharmaceuticals, Inc. in the period of last 50 days is set at 4.27%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 5.63%. In the last 20 days, the company’s Stochastic %K was 42.46% and its Stochastic %D was recorded 59.07%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -62.31%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -62.05%, alongside a downfall of -41.31% for the period of the last 12 months. The shares increased approximately by 22.08% in the 7-day charts and went down by -42.19% in the period of the last 30 days. Common stock shares were lifted by -28.19% during last recorded quarter.